Patient enrollment and study design
abnormal coagulation, suppurative, non-healing, pathologically-diagnosed gynecological cancer, rheumatism, rheumatoid
ALLERGIC ECZEMA, ENDOMETRIAL CANCER, ABNORMAL COAGULATION, CHRONIC INFECTION, SUPPURATIVE, DISEASE, CHRONIC NEPHRITIS, HIV INFECTION, RHEUMATISM, DISEASES
Eighty women with pathologically-diagnosed gynecological cancer were enrolled in this study. Written consent was obtained from all patients to provide information and samples for research purposes. The inclusion criteria were: (1) female patients aged 18–85 years; (2) pathological diagnosis of cervical or endometrial cancer; (3) ECOG score > 2 and an estimated survival time of > 3 months; (4) Dalian local Chinese Han population ethnicity. The exclusion criteria were: (1) diagnosed with suppurative and chronic infection, or non-healing wound; (2) diagnosed with disease of the immune system (chronic nephritis, rheumatism, rheumatoid diseases, allergic eczema, HIV infection, or other disease); (3) abnormal coagulation function or other blood system diseases; (4) pregnancy, lactating, or fertile but not taking effective contraceptive measures; (5) antibiotics or probiotics used within the previous two weeks.Participants were randomly divided into the control group and the Study design.